Navigation Links
New ballast treatment could protect Great Lakes fish
Date:6/4/2008

A Michigan Technological University professor has developed a new water treatment that could help keep a deadly fish disease out of Lake Superior.

David Hand, a professor of civil and environmental engineering at Michigan Tech, has devised a simple way to treat ballast water in vessels ranging from pleasure craft to ore boats. His method is designed to kill the virus that causes viral hemorrhagic septicemia (VHS), an often-fatal disease that has been attacking fish populations in the lower Great Lakes.

Hand's treatment is simple.

The ballast water is disinfected with sodium hypochloriteordinary household bleach. Then it is treated with ascorbic acid, or vitamin C, which neutralizes the bleach before the water is released into the lake.

With good initial results, Hand has tested his method on the Ranger III, a National Park Service vessel that shuttles visitors and staff between the mainland and Isle Royale National Park.

In the next few weeks, the Great Ships Initiative will conduct independent lab tests on his system at the University of WisconsinSuperior to help determine if it is safe, effective and inexpensive. Other partners in the effort are the National Park Service and the US Fish and Wildlife Service.

"VHS has had a devastating effect on the musky population in Lake St. Clair and affects 23 species of game fish," said Phyllis Green, superintendent of Isle Royale National Park and the midwest coordinator of the park service's VHS Prevention Team. "It's important that we keep it out of the Lake Superior basin or at least slow its spread. Our aim is to find a low-tech, low-cost, interim solution that can stop the spread of VHS."

Since 2003, VHS it has caused massive dieoffs of fish species ranging from walleyes to salmon in all of the Great Lakes except Superior. Infected fish die from bleeding of their internal organs and often have open sores and bruised-looking, reddish tints on their skin.

As bad as it is, VHS is only part of the problem Hand wants to address. Exotic species have been hitchhiking throughout the Great Lakes via ballast tanks since 1959, when the St. Lawrence Seaway opened. And, as global trade increases, the problem will only get worse.

"Ships unload their ballast water from all over the world, and with it all kinds of exotic, invasive species, from viruses and bacteria to the zebra mussel," said Hand.

It's unfair to point the finger only at ocean-going ships, says Hand, a devoted angler and boat owner himself. All boaters should sterilize their bilge, ballast and livewell water.

"Not only do we need to prevent the salties from bringing in new viruses, we also need the lake carriers from the lower Great Lakes to treat their ballast, because the VHS virus is already in Lakes Huron, Michigan and Erie, and we don't want it in Superior," he said. "We really need something for all ships, as well as pleasure boats."

"We all need to protect the resource," he said.

If tests show that his system is as safe and effective as he believes, Hand hopes to map a strategy to implement its use throughout the Great Lakes.


'/>"/>

Contact: Jennifer Donovan
jdonovan@mtu.edu
906-487-4521
Michigan Technological University
Source:Eurekalert

Related biology news :

1. U-M ballast-free ship could cut costs while blocking aquatic invaders
2. Quest for better treatment for effects of menopause
3. Sugar linkage could lead to better treatment for autoimmune diseases
4. Glypican-3 gene function in regulating body size helps inform novel cancer treatments
5. Early treatment of stomach infection may prevent cancer
6. New surgery improves head and neck cancer treatment
7. Hyperviscous fluids: Better treatment for severe blood loss
8. Pregnancy is possible after cancer treatment
9. Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
10. Research identifies first method for testing, assessing drug treatments for Chagas disease
11. Pregnant patients lose out in breast cancer treatment; a new approach is needed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Ore. , Feb. 22, 2017  IBM (NYSE: ... (Avamere Health Services, Infinity Rehab, Signature Hospice, Home Health, ... will apply the power of IBM cognitive computing to ... centers. By analyzing data streaming from sensors in senior ... and environmental conditions, and obtain deeper learnings into the ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
(Date:2/8/2017)... 2017 About Voice Recognition Biometrics Voice recognition ... against a stored voiceprint template. Acoustic features of ... tone are compared to distinguish between individual voices. ... most PCs already have a microphone and can ... biometrics are most likely to be deployed in ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... 2017 Agenus Inc. (NASDAQ: AGEN), an immuno-oncology ... cancer vaccines, today announced participation at the following conferences: ... Blair and Maidstone Life Sciences conference "Cancer Immunotherapy Conference" ... New York, NY . Agenus will participate ... 9:40 am: Robert B. Stein , M.D., Ph.D., ...
(Date:3/23/2017)... ... March 23, 2017 , ... Lajollacooks4u is proud to announce it has become the ... corporate cooking challenges for companies around the world, such as Illumina, HP and Qualcomm, and ... reason for its increasing popularity is due to its new team building format, a way ...
(Date:3/23/2017)... , March 23, 2017  Northwest Biotherapeutics (OTCQB: ... personalized immune therapies for solid tumor cancers, today ... million financing it announced last Friday, March 17, ... several institutional investors securities totaling 28,843,692 shares, comprised ... and 10,000,000 shares of Class C Warrants pre-funded ...
(Date:3/23/2017)... 2017  GlobeImmune, Inc. today announced it has entered ... 12,835,490 shares of its common stock to NantCell, Inc., ... with the sale of its common stock, NantCell has ... to GlobeImmune 200,000 shares, an estimated $2.0 million in ... are pleased to enter into this strategic agreement with ...
Breaking Biology Technology: